Preclinical Studies

Astrogenetix Services offers design programs allowing pharmaceutical customers access to data generated from microgravity protocols during the discovery and pre-clinical phases of drug development. Building on the company’s comprehensive internal programs, Astrogenetix offers unprecedented access to the microgravity environment for a host of potential commercial customers. The company provides a complete range of services from pre-flight project design to on-orbit processing through final post-flight analysis, sample processing and data analysis. In addition, the company provides data and other information about the composition of new drug entities (NDEs), their safety profiles, formulations and how they will be administered to the first human subjects. This expertise is coupled with our own clinical experience and our interaction with the U.S. food and drug administration (FDA), as well as with other regulators around the world. Astrogenetix also employs a rigorous set of standards and methodologies for experimental protocol design that will assure that microgravity processing will not only be understood by the regulating bodies, but also become the gold standard for processing pharmaceutical research in space.